Release Date: 05/10/22 16:45 Summary: Announcement under ASX Operating Rule 10A.4.3 Price Sensitive: No Download Document 100.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%